Neurogene Inc.

NGNE | NASDAQ

Price Alert Chart Builder DCF Calculator

$32.57

+$0.48 (+1.50%)

At close: Sep 21, 2026, 4:00 PM ET

$32.57

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-90.35M	-75.14M	-36.32M	-55.19M	-50.52M	-33.28M
Depreciation & Amortization	3.09M	3.25M	3.3M	3.2M	947K	1.82M
Stock-Based Compensation	14.18M	8.32M	1.42M	1.25M	896K	n/a
Other Working Capital	-359K	-5.88M	-4.69M	912K	-1.39M	966K
Other Non-Cash Items	-4.37M	-1.07M	-15.69M	608K	679K	5.92M
Deferred Income Tax	n/a	n/a	-105K	n/a	n/a	n/a
Change in Working Capital	268K	-5.96M	-4.02M	-2.7M	1.6M	966K
Operating Cash Flow	-77.17M	-70.6M	-51.42M	-52.82M	-46.4M	-24.58M
Capital Expenditures	-1.18M	-808K	-321K	-2.23M	-18.37M	-2.22M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-269.51M	-198.45M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	284.7M	74M	5M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	20.96M	n/a	n/a	n/a
Investing Cash Flow	14M	-125.26M	25.64M	-2.23M	-18.37M	-2.22M
Debt Repayment	-61K	-52K	-29K	-1K	n/a	-49K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-5.47M	168K	n/a	n/a	n/a
Financial Cash Flow	30.43M	184.07M	92.48M	66.53M	51.06M	77.14M
Net Cash Flow	-32.74M	-11.79M	66.7M	11.48M	-13.71M	49.46M
Free Cash Flow	-78.36M	-71.41M	-51.74M	-55.05M	-64.77M	-26.79M
Adj. Free Cash Flow	-92.54M	-79.73M	-53.16M	-56.31M	-65.67M	-26.79M
Maintenance CapEx	-1.18M	n/a	-321K	-2.23M	-18.37M	-2.22M
Growth CapEx	n/a	-808K	n/a	n/a	n/a	n/a
Owner Earnings	-78.36M	-70.6M	-51.74M	-55.05M	-64.77M	-26.79M